- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 362
Karslake slides into UChicago’s Polsky Center
Christine Karslake is set to lead UChicago’s Polsky Science Ventures unit and will be tasked with setting up a deep tech-focused accelerator.
Jan 20, 2021PPRO progresses with $180m
The PayPal and Citi-backed cross-border payment technology provider has raised new funding at a valuation topping $1bn.
Jan 20, 2021US universities launch Academic Accelerator
Indiana University is among four US institutions selected by the US Department of Defense's open national security innovation programme for a new accelerator targeting applied research spinouts.
Jan 20, 2021AltPep unpacks $23.1m round
University of Washington spinout AltPep will use the money to advance work on its lead asset that targets Alzheimer’s disease.
Jan 20, 2021Globality gulps down $138m in series E
SoftBank Vision Fund returned to reinvest in the outsourcing marketplace operator at a valuation of almost $1bn to take its total funding to $310m.
Jan 20, 2021Vor Biopharma goes for $150m in IPO
PureTech Health, Johnson & Johnson and Novartis are in line for exits after the cancer drug developer filed for its initial public offering.
Jan 20, 2021Sensei looks to master public markets
Cambrian Biopharma is the largest investor in cancer immunotherapy developer Sensei Biotherapeutics, which has filed to raise up to $100m.
Jan 20, 2021Verve Therapeutics turns to $94m series B
Novo and existing backer GV participated in a round that lifted the heart disease drug developer's overall funding to more than $215m.
Jan 20, 2021AltPep unpacks series A funding
University of Washington spinout AltPep will use the proceeds from the Alexandria Venture Investments-backed round to advance a lead asset targeting Alzheimer’s disease.
Jan 20, 2021Neel Ray joins Envestnet
Ray's previous job at TD Ameritrade involved participation in investments including enterprise automation software provider HyperScience.
Jan 20, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


